784-6 Unexplained Heart Failure in Cardiac Transplant Recipients: Intracoronary Ultrasound Identifies Two Distinct Subgroups  by Wiedermann, Joseph G. et al.
334A ABSTRACfS lACC February 1995
1784-51 Gene Transfer in a Rabbit Model of Allograft
Vasculopathy
11 :30 unchanged at 3 months despite high-dose steroids, Group II may represent
cellular rejection not sampled during biopsy, or a steroid-responsive acute
myopathy.
Correlation Ll. Change
EF RWMSI EF RWMSI
Inter-observer 084" 0.81" 0.05 ± 8.4% 0.04 ± 0.2S
Intra-observer 08S" 0.8S" -0.31 ± 6.5% 0.07 ± 0.23"
Subbarao Chavali, Peter S. Rahko, Ford Ballantyne III. Cardiology Section, University
of V'lhsconsin, Madison, WI
Left ventricular regional and global function is predominantly evaluated by
semiquantitative scoring systems, yet little information exists on inter- and
intra-observer variability. We evaluated 97 pts. with known LV dysfunction
to assess the intra- and inter-observer variability of 2 scoring systems. Stan-
dard parasternal and apical 2-D imaging views were scored by 2 experienced
echocardiographers blinded to each other using the American Society of
Echocardiography 16 segment model. One observer reanalyzed the stud-
ies after a 3 month interval. In System A, segments were graded normal
1+, mildly hypokinetic 1.5+, hypokinetic 2+, severely hypokinetic 2.5+, aki-
netic 3+ or dyskinetic 4+, In system B grades were normal 1+, hypokinetic
2+, akinetic 3+ and dyskinetic 4+. Global function was assessed with a re-
gional wall motion score index IRWMSI) (sum of segment scores/# of seg-
ments scored) and by visually estimating EF. Results: We scored 1458 (94%)
of the available segments. Inter and intra-observer correlations were high
and showed minimal systematic bias:
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Echo Cardiographic Assessment of LV
Junction
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Automated Boundary Detection (ABD). recently incorporated into standard
echocardiographic system, provides an on-line instantaneous measurement
of left ventricular (LVI volume and its derivative as a function of time (dV/dt).
The aim of our study was to test the clinical feasibility of ABD in monitoring
acute LV changes. We evaluated the LV response to acute changes in preload
in 15 normal males (mean age 32 ± 6 years), examined 5 times: in the supine
position (A). with legs elevated 45° to 60° (B). back in the supine position
IC), 5' after the simultaneous inflation of blood pressure cuffs at the root
of the 4 limbs (D) (pressure of the cuffs set at 10 mmHg below the basal
diastolic pressure of each subject) and back in the supine position (E). Real
time LV volumes by ABD were obtained in the 4 chamber view, with gains
optimized to detect the most continuous ABD. We evaluated: systolic (SBP)
and diastolic blood pressure (DB PI, heart rate (HR), LV end-diastolic (EDV)
and end-systolic volume (ESV). ejection fraction (EF). normalized peak filling
"p < 0.05
For regional function, segment scores differed by 2 or more units in 35
12%1 segments (interobserver) and in 16 (1 %) segments (intraobserver). For
System A there was full interobserver agreement in 710 (49%) segments,
(range 37-60% for individual segments) and full intraobserver agreement in
889 (57%) segments (range 43-73%. For system B, full interobserver agree-
ment was significantly higher at 951 (66%)" segments (range 51-76%) as
was full intraobserver agreement at 1094 (74%)" segments (range 62-82%).
Conclusions: 1) Intraobserver variability is less than interobserver variability
for both global and regional assessment of LV function. 2) Asegmental score
change of 2 units is highly reliable. 3) Attempts to increase the number of
gradations of wall motion scoring over the current clinical standard (system
B) reduces reliability significantly. 4) The estimated EF must change> 17%
between observers or > 13% serially by the same observer to reliably indi-
cate a significant change.
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Clinical Feasibility of Echocardiographic Automated
Boundary Detection in Monitoring Left Ventricular
Response to Acute Changes of Preload in Normal
Subjects
Anna M. Grandi, Massimo Bignottl, Barbara Nardo, Paolo Zanzi, Andrea Bertolini,
Luigina Guasti, Achille Venco Department of Internal Medicine, University of Pavia,
section of Varese, Italy
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Cardiac allograft vasculopathy is a diffuse process that involves the entire
vascular bed of the transplanted allograft. including the portion of the donor
aorta. The purpose of this study was to assess the feasibility of gene trans-
fer and to examine the duration of gene expression in a rabbit heterotopic
aortic transplant model of allograft vasculopathy. The abdominal aortas of 1B
outbred New Zealand rabbits were harvested and cross-sectionally bisected.
One-half of each was administered a control solution while the other half was
incubated with a recombinant adenoviral vector encoding CMV promoter-
regulated ,IJ-galactosidase. Following a 20-minute incubation, bilateral aor-
tocarotid transplants were performed in 1B recipient rabbits. All animals re-
ceived cyclosporine immunosuppression (1 0 mglkg/day,sq). The allografts (n
= 36) were harvested at 3, 7, 10, 14,21, and 28 days after transplantation and
assayed for ,IJ-galactosidase activity. In addition, the allografts were stained
for elastin with Verhoeff stain and neointimal to media ratio was calculated.
Results:
Mandeep R. Mehra, Dwight D. Stapleton, R. Wayne Barbee, Tonglin Zhang, Hector
O. Ventura, Frank W. Smart, Blanca Maldonado, Chin-Hu Huang, Trisha
M. Rosenbohm, Joseph P Murgo, Richard N. Re, Julia L. Cook Ochsner Medical
Institutions, New Orleans, LA
No ,IJ-galactosidase expression was observed in control aortas (except at
suture sites).
Conclusions: These results demonstrate optimal gene expression during
maximal vascular allograft intimal proliferation and suggest that this model
is useful in studying the potential of gene therapy in allograft vasculopathy.
Joseph G. Wiedermann, Ronald Drusin, Howard Levin, Allan Schwartz,
Mark Apfelbaum Columbia University, New York, NY
Cryptogenic heart failure in cardiac transplant recipients (CTR) is frequently
attributed to humoral rejection. Histopathology in humoral rejection has iden-
tified angiographically silent coronary intimal thickening. We studied trans-
plant patients with unexplained CHF using intracoronary ultrasound (ICUS)
to identify occult CAD. Twelve CTR (8 male, 4 female; age 51 ± 15 years;
2-7 years post-transplant) were referred for angiography and ICUS because
of recent-onset CHF (radionuclide EF < 30%). All patients had normal coro-
nary arteries by angiography at their previous surveillance catheterization,
no recent infections, and no biopsy evidence of cellular rejection. ICUS was
performed with 4.3F, 30 mHz imaging catheters to the distal LAD andlor LCX.
Images were analyzed via computer-planimetry for intimal thickness liT). All
12 patients had normal angiograms. All patients were treated with high-dose
IV steroids. Surviving patients had repeat radionuclide EF at 3 months. Five
patients (Group I) had significant intimal thickening by ICUS (IT = 0.66 ± 0.1 0
mm, for::: 180° of vessel circumference). Seven patients (Group II) had no ab-
normal intimal thickening (IT = 0.26 ± 0.06 mm). Group I vs. II, P < 0.001.
At three months, EF in Group I survivors was unchanged (2 patients died);
Group II patients (none died) experienced a 21 ± 9 point improvement in EF
(p < 0.011.
Conclusions: ICUS segregates CTR with cryptogenic CHF (and normal an-
giograms) into two groups; one with marked intimal thickening, and one with
normal intima. These groups have markedly different prognoses. Group I may
represent patients with ongoing humoral rejection; EF in these patients is
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